Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression
D. R. Hoover, Y. Peng, A. Saah, R. Semba, R. R. Detels, C. R. Rinaldo Jr and J. P. Phair
Department of Epidemiology, School of Public Health, Johns Hopkins University, Baltimore, Md., USA.
OBJECTIVE: To estimate the incidence and prevalence of cytomegalovirus
retinitis (CMV-R) in late-stage human immunodeficiency virus type 1
disease. DESIGN: Cohort study. SETTING: The Multicenter AIDS Cohort Study,
an ongoing 10-year study of human immunodeficiency virus type 1-infected
homosexual men with semiannual visits and CD4+ cell testing. STUDY
PARTICIPANTS: Three hundred sixty-seven human immunodeficiency virus type
1-infected men from the Multicenter AIDS Cohort Study who were receiving
zidovudine and Pneumocystis carinii prophylaxis and who had CD4+ cell
counts fall below 0.10 x 10(9)/L (100/microL). MAIN OUTCOME MEASURES:
Kaplan-Meier-type estimates for various longitudinal quantifications of
incidence and prevalence of CMV-R were obtained. RESULTS: Among these 367
individuals, cytomegalovirus disease developed in 103, of whom 73 (71%) had
ocular complications. At 4 years after the first CD4 cell count ( < 0.10
x 10(9)/L), the probability for these subjects to have (1) remained living
without CMV-R was 11%, (2) died without experiencing CMV-R was 66%, (3)
experienced CMV-R and be living was 6%, and (4) experienced CMV-R and died
was 18%. During these 4 years, there was a 25% chance for the development
of CMV-R and, on average, 0.211 person-years of CMV-R morbidity. Among
those subjects in whom CMV-R developed, about 19% did have CMV-R before a
CD4+ cell count of less than 0.05 x 10(9)/L ( < 50/microL) was observed,
and 81% had CMV-R after the CD4+ cell count reached this threshold.
CONCLUSION: These estimates may be relevant to current clinical practice
and help in allocating resources and planning for treatment and prophylaxis
against cytomegalovirus disease.
AIDS and Ophthalmology in 2004
Jabs
Arch Ophthalmol 2004;122:1040-1042.
FULL TEXT
Risk of Vision Loss in Patients With Cytomegalovirus Retinitis and the Acquired Immunodeficiency Syndrome
Kempen et al.
Arch Ophthalmol 2003;121:466-476.
ABSTRACT
| FULL TEXT
Ocular disease in patients with tuberculosis and HIV presenting with fever in Africa
Beare et al.
Br. J. Ophthalmol. 2002;86:1076-1079.
ABSTRACT
| FULL TEXT
Up-Regulation of Fas Ligand Expression by Human Cytomegalovirus Immediate-Early Gene Product 2: A Novel Mechanism in Cytomegalovirus-Induced Apoptosis in Human Retina
Chiou et al.
J. Immunol. 2001;167:4098-4103.
ABSTRACT
| FULL TEXT
Discontinuing anticytomegalovirus therapy in patients with cytomegalovirus retinitis and AIDS
JABS
Br. J. Ophthalmol. 2001;85:381-382.
FULL TEXT
Retinal Detachment Risk in Cytomegalovirus Retinitis Related to the Acquired Immunodeficiency Syndrome
Kempen et al.
Arch Ophthalmol 2001;119:33-40.
ABSTRACT
| FULL TEXT
Murine Cytomegalovirus Infection Causes Apoptosis of Uninfected Retinal Cells
Bigger et al.
IOVS 2000;41:2248-2254.
ABSTRACT
| FULL TEXT
Entry of Human Cytomegalovirus into Retinal Pigment Epithelial and Endothelial Cells by Endocytosis
Bodaghi et al.
IOVS 1999;40:2598-2607.
ABSTRACT
| FULL TEXT
Protection against Murine Cytomegalovirus Retinitis by Adoptive Transfer of Virus-Specific CD8+ T Cells
Bigger et al.
IOVS 1999;40:2608-2613.
ABSTRACT
| FULL TEXT
Comparison of Cytomegalovirus Loads in Plasma and Leukocytes of Patients with Cytomegalovirus Retinitis
Jabs et al.
J. Clin. Microbiol. 1999;37:1431-1435.
ABSTRACT
| FULL TEXT
Treatment of immune recovery vitritis with local steroids
Henderson and Mitchell
Br. J. Ophthalmol. 1999;83:540-545.
ABSTRACT
| FULL TEXT
Role of IFN-{gamma}-Induced Indoleamine 2,3 Dioxygenase and Inducible Nitric Oxide Synthase in the Replication of Human Cytomegalovirus in Retinal Pigment Epithelial Cells
Bodaghi et al.
J. Immunol. 1999;162:957-964.
ABSTRACT
| FULL TEXT
Incidence of Foscarnet Resistance and Cidofovir Resistance in Patients Treated for Cytomegalovirus Retinitis
Jabs et al.
Antimicrob. Agents Chemother. 1998;42:2240-2244.
ABSTRACT
| FULL TEXT
Risk of developing CMV retinitis following non-ocular CMV end organ disease in AIDS patients
Verbraak et al.
Br. J. Ophthalmol. 1998;82:748-750.
ABSTRACT
| FULL TEXT
Clinical Failure of CMV Retinitis With Intravitreal Cidofovir Is Associated With Antiviral Resistance
Smith et al.
Arch Ophthalmol 1998;116:178-185.
ABSTRACT
| FULL TEXT